In the comparison of the controls against each patient group including “random,” “stroke,” and “long survivor” groups, we found PLAT and SLC19A2 [MIM: 603941] to be consistently significant in gene‐specific differences in allele frequencies across all the comparisons (Table S4). This evidence concerns the gene SLC19A2 and Stroke.